Article
Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - 1 Nov 2021
Qadir Mehmood, Tahseen Sabira, McHugh Timothy D, Hussain Alamdar, Masood Faisal, Ahmed Niaz, Faryal Rani
Abstract excerpt
INTRODUCTION: Rifampicin (RIF) is one of the most effective anti-tuberculosis first-line drugs prescribed along with isoniazid. However, the emergence of RIF resistance Mycobacterium tuberculosis (MTB) isolates is a major issue towards tuberculosis (TB) control program in high MDR TB-burdened countries including Pakistan. Molecular data behind phenotypic resistance is essential for better management of RIF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
